MTNB Annual Short Term Debt
$661.00 K
+$92.00 K+16.17%
31 December 2023
Summary:
As of January 23, 2025, MTNB annual short term debt is $661.00 thousand, with the most recent change of +$92.00 thousand (+16.17%) on December 31, 2023. During the last 3 years, it has risen by +$238.60 thousand (+56.49%). MTNB annual short term debt is now at all-time high.MTNB Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MTNB Quarterly Short Term Debt
$738.00 K
+$26.00 K+3.65%
30 September 2024
Summary:
As of January 23, 2025, MTNB quarterly short term debt is $738.00 thousand, with the most recent change of +$26.00 thousand (+3.65%) on September 30, 2024. Over the past year, it has increased by +$101.00 thousand (+15.86%). MTNB quarterly short term debt is now at all-time high.MTNB Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MTNB Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.2% | +15.9% |
| 3 y3 years | +56.5% | +15.9% |
| 5 y5 years | +133.5% | +15.9% |
MTNB Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.0% | at high | +34.7% |
| 5 y | 5-year | at high | +56.5% | at high | +95.2% |
| alltime | all time | at high | at high |
Matinas BioPharma Holdings Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $738.00 K(+3.7%) |
| June 2024 | - | $712.00 K(+3.8%) |
| Mar 2024 | - | $686.00 K(+3.8%) |
| Dec 2023 | $661.00 K(+16.2%) | $661.00 K(+3.8%) |
| Sept 2023 | - | $637.00 K(+3.9%) |
| June 2023 | - | $613.00 K(+4.1%) |
| Mar 2023 | - | $589.00 K(+3.5%) |
| Dec 2022 | $569.00 K(+1.6%) | $569.00 K(+3.9%) |
| Sept 2022 | - | $547.90 K(-7.3%) |
| June 2022 | - | $590.80 K(+2.6%) |
| Mar 2022 | - | $575.80 K(+2.8%) |
| Dec 2021 | $560.00 K(+32.6%) | $560.00 K(+3.1%) |
| Sept 2021 | - | $543.10 K(+43.6%) |
| June 2021 | - | $378.10 K(-4.0%) |
| Mar 2021 | - | $394.00 K(-6.7%) |
| Dec 2020 | $422.40 K(-11.7%) | $422.40 K(-6.2%) |
| Sept 2020 | - | $450.20 K(-5.9%) |
| June 2020 | - | $478.40 K(-1.1%) |
| Mar 2020 | - | $483.50 K(+1.1%) |
| Dec 2019 | $478.40 K | $478.40 K(+1.0%) |
| Sept 2019 | - | $473.80 K(+1.6%) |
| June 2019 | - | $466.40 K(-13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $536.40 K(+89.5%) |
| Dec 2018 | $283.10 K(+43.6%) | $283.10 K(-29.8%) |
| Sept 2018 | - | $403.10 K(+664.9%) |
| June 2018 | - | $52.70 K(-44.1%) |
| Mar 2018 | - | $94.30 K(-52.2%) |
| Dec 2017 | $197.20 K(+54.1%) | $197.20 K(-37.8%) |
| Sept 2017 | - | $316.90 K(+1585.6%) |
| June 2017 | - | $18.80 K(-67.2%) |
| Mar 2017 | - | $57.40 K(-55.2%) |
| Dec 2016 | $128.00 K(+1032.7%) | $128.00 K(-35.5%) |
| Sept 2016 | - | $198.60 K(+1968.8%) |
| June 2016 | - | $9600.00(>+9900.0%) |
| Mar 2016 | - | $0.00(-100.0%) |
| Dec 2015 | $11.30 K(-74.5%) | $11.30 K(-65.2%) |
| Sept 2015 | - | $32.50 K(-25.5%) |
| June 2015 | - | $43.60 K(-20.1%) |
| Mar 2015 | - | $54.60 K(+23.0%) |
| Dec 2014 | $44.40 K(>+9900.0%) | $44.40 K(+0.7%) |
| Sept 2014 | - | $44.10 K(+0.7%) |
| June 2014 | - | $43.80 K(-1.6%) |
| Mar 2014 | - | $44.50 K(>+9900.0%) |
| Dec 2013 | $0.00 | $0.00 |
FAQ
- What is Matinas BioPharma Holdings annual short term debt?
- What is the all time high annual short term debt for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual short term debt year-on-year change?
- What is Matinas BioPharma Holdings quarterly short term debt?
- What is the all time high quarterly short term debt for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly short term debt year-on-year change?
What is Matinas BioPharma Holdings annual short term debt?
The current annual short term debt of MTNB is $661.00 K
What is the all time high annual short term debt for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual short term debt is $661.00 K
What is Matinas BioPharma Holdings annual short term debt year-on-year change?
Over the past year, MTNB annual short term debt has changed by +$92.00 K (+16.17%)
What is Matinas BioPharma Holdings quarterly short term debt?
The current quarterly short term debt of MTNB is $738.00 K
What is the all time high quarterly short term debt for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly short term debt is $738.00 K
What is Matinas BioPharma Holdings quarterly short term debt year-on-year change?
Over the past year, MTNB quarterly short term debt has changed by +$101.00 K (+15.86%)